FDA Clears Glaxo Diarrhea-Virus Vaccine
(AP) -- Drugmaker GlaxoSmithKline has received federal approval for a vaccine to stop the leading cause of diarrhea in infants, a market dominated by rival Merck.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
» Next Article in Medicine & Health - Medications: Drug does not appear to reduce risk of heart attack or death following CABG surgery

Rating: n/a
Bookmark
Save as PDF
Print
Email
Blog It
Stumble It!


PhysOrg Forum
Video
Editorials
Free Magazines
Free White Papers
Newsletter
Advanced Search
Goto Archive
Suggest a story idea
Send feedback